| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income | 48,537 | 7,556 | 21,394 | 10,019 |
| Net loss | -666,737 | -740,519 | -1,017,092 | -941,002 |
| Non cash deemed dividend | - | - | - | 3,212,504 |
| Net loss attributable to common stockholders | -666,737 | - | - | -4,153,506 |
| Loss per share - basic | -0.37 | -1.33 | -0.32 | -2.37 |
| Loss per share - diluted | -0.37 | -1.33 | -0.32 | -2.37 |
| Weighted average shares outstanding - basic | 1,795,097 | 557,787 | 3,183,191 | 1,753,409 |
| Weighted average shares outstanding - diluted | 1,795,097 | 557,787 | 3,183,191 | 1,753,409 |
Bone Biologics Corp (BBLG)
Bone Biologics Corp (BBLG)